RE:RE:RE:around November 24th (ER)
I agree it is way undervalued. Working with Hyasynth biosynthesis into their portfolio, will push them ahead faster in the near future. The time line is very quick to get such things as drinks into their catalogue. I think 2021 will be a great year for them.